Clinicians Who Tout Use of AI Risk Undermining Patient Trust, Study Finds
Clinicians who advertised use of AI for diagnostic, therapeutic, even administrative purposes were rated poorly on empathy, trustworthiness, and competence.
Digital Asthma Self Management Program Improves Symptom Control But Disparities in Benefit Are Clear
A smartphone-based asthma management program significantly enhanced symptom control, but may require engagement or cultural tailoring to expand the effect.
Shingrix Prefilled Syringe Gets FDA Greenlight, According to GSK
The prefilled syringe presentation streamlines administration of the vaccine, eliminating the need to combine the lyophylized antigen and separate adjuvant.
Phase 3 Trials Begin for Once-Monthly Oral HIV Prevention Pill
Merck has launched phase 3 trials for MK-8527, a promising once-monthly HIV prevention pill, aiming to enhance PrEP options globally.
Digital Latency Measures Refine Early Detection of Cognitive Decline: Expert Review of Evidence
Digital latency measures enhance early detection of cognitive decline, revealing neurodegenerative changes before traditional tests indicate impairment.
Treatment of Neuropathic Pain: A Close Look at a New Meta-Analysis
For the often treatment-resistant pain of neuropathic conditions, the meta-analysis includes updated evidence for both pharmacologic and neuromodulatory interventions.
Otsuka and Lundbeck Will Face Scrutiny Over Investigational PTSD Therapy at July 18 FDA AdComm Meeting
FDA's Psychopharmacologic Drugs Advisory Committee will evaluate the novel brexpiprazole/sertraline combination, weighing efficacy against existing therapies amid mixed trial results.
Pre- and Post-Menopausal Hormone Therapy Has Differential Effect on Breast Cancer Subtypes
Combined estrogen-progestin hormone therapy used to manage VMS of menopause was associated with a higher risk of developing luminal-like breast cancer subtypes and other subtypes.
Physicians Alarmed by Fad Diets on Social Media: Daily Dose
Your daily dose of the clinical news you may have missed.
Monu Khanna, MD, on Why Cardiometabolic Screening Must Start Early in Patients with Obesity
Dr Khanna urges early screening for cardiometabolic risk in patients with obesity and highlights the role of primary care in prevention and education.
Lifestyle Medicine Is At a Tipping Point in the US, Expert Says, And It Could Be Just in Time
Without a shift in the approach to disease prevention and management in the US, the health system won't be able to handle the burden of our morbidity, says Richard Rosenfeld, MD, MPH, MBA.
Weight Loss Achievable Despite Interruptions in GLP-1 Medication Access, Study Finds
ENDO 2025. People with inconsistent access to GLP-1 medications still achieved clinically significant weight loss when therapy was combined with lifestyle changes and coaching.
New Guidelines Recommend Preconception Screening in Diabetes, Universal Testing for Primary Aldosteronism
ENDO 2025: The publications reflect growing consensus that integration of endocrine screening into standard clinical workflows is essential for early risk detection and long-term disease prevention.
Dupilumab Sustains Long-Term Reduction of S. aureus in People with AD: Daily Dose
Obesity Redefined: 1 in 5 Adults Reclassified Under New EASO Criteria
Individuals newly classified with obesity using the European framework were found to be overall sicker and at greater risk for mortality.
"Everyone is a Candidate for Some Positive Lifestyle Change," Guideline Author Suggests
Richard Rosenfeld, MD, MPH, MBA, led the development of lifestyle medicine guidelines to treat or even reverse prediabetes and type 2 diabetes.
Population-Wide Study Finds No Link Between Aluminum Exposure in Vaccines and Childhood Disorders
The Danish study analyzed a nationwide cohort of 2.1 million children and found no association between aluminum exposure and allergic, autoimmune, or neurodevelopmental conditions.
Lebrikizumab Found Safe, Effective in Patients With Skin of Color With AD: Daily Dose
ENDO 2025: Most Patients With Classic Congenital Adrenal Hyperplasia Experience High Glucocorticoid Exposure or Suboptimal Control
A new analysis of the CAHtalog phase 3 study showed approximately 95% of participants experienced either high glucocorticoid exposure or elevated androstenedione levels during treatment.
The Role of Stress Reduction in Cardiometabolic Disease Management for Patients with Obesity
Monu Khanna, MD, discusses the benefits of behavioral strategies, including yoga, breathwork, and dancing, in reducing cardiovascular disease risk in patients with obesity.
